Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mazzei

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
ESMO Open|February 23, 2024
Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM)R Berardi, F Rossi, R Papa, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Interactions between triazoles and amphotericin B against Cryptococcus neoformansF Barchiesi, A M Schimizzi, F Caselli, et al.
The Pharmacogenomics Journal|October 22, 2014
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatinE Cecchin, G Perrone, S Nobili, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
ESMO Open|February 23, 2024
Gender oncology: recommendations and consensus of the Italian Association of Medical Oncology (AIOM)R Berardi, F Rossi, R Papa, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Interactions between triazoles and amphotericin B against Cryptococcus neoformansF Barchiesi, A M Schimizzi, F Caselli, et al.
The Pharmacogenomics Journal|October 22, 2014
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatinE Cecchin, G Perrone, S Nobili, et al.
Pageof 11